165 related articles for article (PubMed ID: 32455668)
1. Freeze-Dried Softisan
Silva MI; Barbosa AI; Costa Lima SA; Costa P; Torres T; Reis S
Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32455668
[TBL] [Abstract][Full Text] [Related]
2. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management.
Ferreira M; Barreiros L; Segundo MA; Torres T; Selores M; Costa Lima SA; Reis S
Colloids Surf B Biointerfaces; 2017 Nov; 159():23-29. PubMed ID: 28779637
[TBL] [Abstract][Full Text] [Related]
3. Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles.
Essaghraoui A; Belfkira A; Hamdaoui B; Nunes C; Lima SAC; Reis S
Nanomaterials (Basel); 2019 Aug; 9(9):. PubMed ID: 31461853
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.
Guada M; Sebastián V; Irusta S; Feijoó E; Dios-Viéitez Mdel C; Blanco-Prieto MJ
Int J Nanomedicine; 2015; 10():6541-53. PubMed ID: 26527872
[TBL] [Abstract][Full Text] [Related]
5. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.
Carreras JJ; Tapia-Ramirez WE; Sala A; Guillot AJ; Garrigues TM; Melero A
Drug Deliv Transl Res; 2020 Apr; 10(2):486-497. PubMed ID: 31811620
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
7. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
8. Application of the human stratum corneum lipid-based mimetic model in assessment of drug-loaded nanoparticles for skin administration.
Moniz T; Costa Lima SA; Reis S
Int J Pharm; 2020 Dec; 591():119960. PubMed ID: 33049358
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
[TBL] [Abstract][Full Text] [Related]
10. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
Guan P; Lu Y; Qi J; Wu W
Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
[TBL] [Abstract][Full Text] [Related]
11. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
Benigni M; Pescina S; Grimaudo MA; Padula C; Santi P; Nicoli S
Int J Pharm; 2018 Jul; 545(1-2):197-205. PubMed ID: 29698819
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action.
Musa SH; Basri M; Fard Masoumi HR; Shamsudin N; Salim N
Int J Nanomedicine; 2017; 12():2427-2441. PubMed ID: 28405165
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
14. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
16. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
[TBL] [Abstract][Full Text] [Related]
17. Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles.
Ali ME; Lamprecht A
Int J Pharm; 2017 Jan; 516(1-2):170-177. PubMed ID: 27845211
[TBL] [Abstract][Full Text] [Related]
18. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
19. Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.
Huang PH; Hu SC; Lee CW; Yeh AC; Tseng CH; Yen FL
Int J Nanomedicine; 2016; 11():1615-27. PubMed ID: 27143883
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis.
Sonawane R; Harde H; Katariya M; Agrawal S; Jain S
Expert Opin Drug Deliv; 2014 Dec; 11(12):1833-47. PubMed ID: 25078031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
